CLINICAL_TRIALS
trial_result
· 2017-12-18
Clinical Trial Update: A Study of Vemurafenib in Participants With Metastatic Melanoma [Phase 3]
Summary
Phase 3 trial update for vemurafenib in metastatic melanoma has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2017-12-18